Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
    22.
    发明授权
    Oligo-2′-deoxynucleotides and their use as pharmaceutical agents with antiviral activity 失效
    寡脱氧核苷酸及其作为具有抗病毒活性的药物的用途

    公开(公告)号:US06329346B1

    公开(公告)日:2001-12-11

    申请号:US08991183

    申请日:1997-12-16

    IPC分类号: A01N4304

    CPC分类号: C07H19/10 C07H19/20 C07H21/00

    摘要: Oligodeoxyribonucleotides in which at least two 2′-deoxy-&bgr;-D-erythro-pentofuranosyl groups are replaced by 2′-deoxy-&bgr;-D-threo-pentofuranosyl groups at both the 5′ end and 3′ end, and oligodeoxyribonucleotides in which at least 20% of the 2′-deoxy-&bgr;-D-erythro-pentofuranosyl groups in consecutive nucleotide building blocks are replaced by 2′-deoxy-&bgr;-D-threo-pentofuranosyl groups and which are composed of 6 to 100 nucleotide building blocks, are suitable for the inhibition of the expression of viral genes and oncogenes by the antisense principle and can be used for the production of pharmaceutical agents with antiviral activity.

    摘要翻译: 在5'末端和3'末端两个脱氧-β-D-赤 - 呋喃糖基被2'-脱氧-β-D-苏 - 戊呋喃糖基取代的寡脱氧核糖核苷酸和其中的寡脱氧核糖核苷酸 连续核苷酸构建单元中2'-脱氧-β-D-赤型 - 戊呋喃糖基的至少20%被2'-脱氧-β-D-苏糖 - 呋喃糖基取代,它们由6至100个核苷酸构建 适用于通过反义原理抑制病毒基因和癌基因的表达,并可用于生产具有抗病毒活性的药剂。

    Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase
    25.
    发明授权
    Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase 有权
    吡咯喹啉醌依赖性可溶性葡萄糖脱氢酶的突变体

    公开(公告)号:US07732179B2

    公开(公告)日:2010-06-08

    申请号:US12250241

    申请日:2008-10-13

    CPC分类号: C12N9/0006

    摘要: A mutant of PQQ-dependent soluble glucose dehydrogenase (s-GDH; EC 1.1.5.2) is provided with improved specificity for glucose as compared to maltose, having a substitution of threonine at position 348 by either glycine, alamine or serine, wherein said mutant additionally comprises, at least one mutation for improving the stability of the mutant and one or more mutation(s) for improving the affinity of the mutant to glucose, and/or one or more mutation(s) for further improving the specificity of the mutant for glucose as compared to maltose, and wherein position 348 correspond to the amino acid positions known from the A. calcoaceticus s-GDH wild-type sequence. Also disclosed are genes encoding such mutant s-GDH, and different applications of these s-GDH mutants, particularly for determining the concentration of glucose in a sample.

    摘要翻译: 与麦芽糖相比,PQQ依赖性可溶性葡萄糖脱氢酶(s-GDH; EC 1.1.5.2)的突变体具有改善的葡萄糖特异性,其具有通过甘氨酸,丙氨酸或丝氨酸取代位置348处的苏氨酸,其中所述突变体 还包含至少一个用于提高突变体的稳定性的突变和用于提高突变体对葡萄糖的亲和力的一个或多个突变,和/或用于进一步提高突变体的特异性的一个或多个突变 用于与麦芽糖相比的葡萄糖,并且其中位置348对应于从A.calcoaceticus s-GDH野生型序列已知的氨基酸位置。 还公开了编码这种突变体s-GDH的基因以及这些s-GDH突变体的不同应用,特别是用于测定样品中葡萄糖浓度。